Section Arrow
BFRI.NASDAQ
- Biofrontera
(Financial Status)
Quotes are at least 15-min delayed:2026/03/29 02:16 EDT
Regular Hours
Last
 0.819
+0.0092 (+1.14%)
Day High 
0.8196 
Prev. Close
0.8098 
1-M High
0.9601 
Volume 
164.43K 
Bid
0.7805
Ask
0.815
Day Low
0.76 
Open
0.8 
1-M Low
0.78 
Market Cap 
9.43M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.85 
20-SMA 0.86 
50-SMA 0.87 
52-W High 1.19 
52-W Low 0.536 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.04/0.14
Enterprise Value
15.26M
Balance Sheet
Book Value Per Share
0.90
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
41.71M
Operating Revenue Per Share
2.49
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health19.38-1.48-7.09%40.92PE
HLNHaleon plc9.8+0.05+0.51%19.79PE
TEVATeva Pharmaceutical Industries Limited28.74-1.04-3.49%24.64PE
ELANElanco Animal Health23.13-1.45-5.90%355.43PE
VTRSViatris13.05-0.32-2.39%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products,which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.